Attached files

file filename
10-Q - FORM 10-Q - Diadexus, Inc.d10q.htm
EX-3.1 - RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT - Diadexus, Inc.dex31.htm
EX-10.6 - AMENDED AND RESTATED 1996 STOCK OPTION PLAN - Diadexus, Inc.dex106.htm
EX-10.7 - FORM OF STOCK OPTION AGREEMENT - Diadexus, Inc.dex107.htm
EX-10.9 - FORM OF INDEMNITY AGREEMENT - Diadexus, Inc.dex109.htm
EX-10.8 - DIADEXUS, INC. RETENTION BONUS PLAN - Diadexus, Inc.dex108.htm
EX-10.24 - AMENDMENT NO. 01 TO THE DIAZYME AGREEMENT - Diadexus, Inc.dex1024.htm
EX-10.23 - SERVICES AND SUPPLY AGREEMENT - Diadexus, Inc.dex1023.htm
EX-10.20 - DEVELOPMENT, MANUFACTURING, AND SUPPLY AGREEMENT - Diadexus, Inc.dex1020.htm
EX-10.28 - DISTRIBUTOR AGREEMENT - Diadexus, Inc.dex1028.htm
EX-10.22 - SECOND AMENDMENT TO THE DENKA SEIKEN AGREEMENT - Diadexus, Inc.dex1022.htm
EX-10.29 - ADDENDUM NO. 1 TO THE BINDING SITE AGREEMENT - Diadexus, Inc.dex1029.htm
EX-10.10 - SB/HGS DIAGNOSTIC LICENSE AGREEMENT - Diadexus, Inc.dex1010.htm
EX-10.26 - AMENDED AND RESTATED SUPPLY AGREEMENT - Diadexus, Inc.dex1026.htm
EX-10.25 - AMENDMENT NO. 2 TO THE DIAZYME AGREEMENT - Diadexus, Inc.dex1025.htm
EX-10.19 - DIAGNOSTICS LICENSE AGREEMENT - Diadexus, Inc.dex1019.htm
EX-10.31 - ADDENDUM NO. 3 TO THE BINDING SITE AGREEMENT - Diadexus, Inc.dex1031.htm
EX-10.21 - FIRST AMENDMENT TO THE DENKA SEIKEN AGREEMENT - Diadexus, Inc.dex1021.htm
EX-10.18 - SIDE LETTER TO LICENSE AGREEMENT - Diadexus, Inc.dex1018.htm
EX-32.1 - CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 - Diadexus, Inc.dex321.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) - Diadexus, Inc.dex311.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) - Diadexus, Inc.dex312.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Diadexus, Inc.dex322.htm
EX-10.37 - FIRST AMENDMENT TO LEASE AGREEMENT - Diadexus, Inc.dex1037.htm
EX-10.44 - LETTER AGREEMENT REGARDING SUBLEASE - Diadexus, Inc.dex1044.htm
EX-10.36 - LEASE, DATED AS OF NOVEMBER 23, 1999 - Diadexus, Inc.dex1036.htm
EX-10.43 - THIRD AMENDMENT TO SUBLEASE - Diadexus, Inc.dex1043.htm
EX-10.38 - ACKNOWLEDGEMENT OF TERM COMMENCEMENT DATE - Diadexus, Inc.dex1038.htm
EX-10.32 - BUSINESS DEVELOPMENT ADDENDUM TO THE DISTRIBUTOR AGREEMENT - Diadexus, Inc.dex1032.htm
EX-10.41 - FIRST AMENDMENT TO SUBLEASE - Diadexus, Inc.dex1041.htm
EX-10.39 - CONSENT TO ASSIGNMENT AND MODIFICATION OF LEASE - Diadexus, Inc.dex1039.htm
EX-10.40 - SUBLEASE, DATED JUNE 1, 2002 - Diadexus, Inc.dex1040.htm
EX-10.33 - MASTER SUPPLY AGREEMENT - Diadexus, Inc.dex1033.htm
EX-10.35 - ADDENDUM NO. 2 TO THE BHL MASTER SUPPLY AGREEMENT - Diadexus, Inc.dex1035.htm
EX-10.42 - SECOND AMENDMENT TO SUBLEASE - Diadexus, Inc.dex1042.htm
EX-10.45 - FOURTH AMENDMENT TO SUBLEASE - Diadexus, Inc.dex1045.htm
EX-10.27 - AGREEMENT, BY AND BETWEEN DIADEXUS, INC. AND DAKO NORTH AMERICA, INC. - Diadexus, Inc.dex1027.htm
EX-10.34 - ADDENDUM NO. 1 TO THE BHL MASTER SUPPLY AGREEMENT - Diadexus, Inc.dex1034.htm

 

Exhibit 10.30

[*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

Addendum No. 2 to the Distribution Agreement

This Addendum No. 2 to the Distribution Agreement (the “Addendum”) is made and entered into as of this 15th day of June, 2007, by and between diaDexus, Inc. (“DIADEXUS”), and The Binding Site (“BINDING SITE”).

WHEREAS, BINDING SITE and DIADEXUS are parties to a Distribution Agreement effective January 30, 2007 and modified it with Addendum No. 1 on February 1, 2007 (collectively, the “Agreement”);

WHEREAS, the parties desire to amend such Agreement as follows:

[*]

Please insert the following into Exhibit A.

[*]

 

Description

  

Unit

   Catalog #    Lab Price

[*] PLAC® Test Kit for Lp-PLA2

  

96-well microplate ELISA kit

   90106    [*]

BINDING SITE recognizes the importance to DIADEXUS that BINDING SITE make best efforts to expedite the rate at which customers go live with commercial sales and new customers are enabled. Accordingly both DIADEXUS and BINDING SITE will review this Addendum No. 2 [*] and if BINDING SITE is making solid commercial efforts to advance Product sales, DIADEXUS will [*].

In addition, all BINDING SITE sales reporting pursuant to Section 3 (c) provided to DIADEXUS shall be certified for financial accuracy by a financial officer of BINDING SITE.


 

IN WITNESS WHEREOF, the parties hereto have caused this Addendum to be executed by their fully authorized representatives.

 

BINDING SITE       DIADEXUS
BY:  

/s/ R. Rowland

    BY:  

/s/ Patrick Plewman

Printed Name: R. Rowland     Printed Name: Patrick Plewman
Title: CEO     Title: President & CEO
Date: 6/15/07     Date: 6/19/07